Why the study?
What is the dose-response relationship and relative potency of oral pindolol on exercise heart rate compared to other beta-blockers in healthy male subjects?
What is the dose-response relationship and relative potency of oral pindolol on exercise heart rate compared to other beta-blockers in healthy male subjects?
Pindolol is a highly potent beta-blocker, but its partial agonist activity results in a lower maximum reduction of exercise heart rate compared to other beta-blockers.
Requires potency-adjusted dosing for pindolol in exercise testing; leaves open comparative efficacy in patients.
The dose-response curve of pindolol on exercise heart rate has been constructed from observations in healthy male subjects studied 2 h after oral doses of pindolol 0.25 mg, 0.5 mg, 1 mg, 2.5 mg, 5 mg, 10 mg and 20 mg. This dose-response curve has been compared with historical controls who received atenolol, oxprenolol, practolol, propranolol and sotalol. 2 The dose-response curves differ in the relative potency of the drug, the maximum reduction of heart rate and possibly in the slope of the curves. Pindolol is extremely potent. At doses which produce 15 % reduction of exercise heart rate, the relative potencies of the drugs were: pindolol ( 1), atenolol (1:21) oxprenolol (1:19), practolol (1:44), propranolol (1:25) and sotalolol (1:160). The maximum effects produced by pindolol, oxprenolol and practolol were less than those of the other P-adrenoceptor blocking drugs, an effect which is probably the result of their partial agonist activity.
No takes yet. Share an insight, caveat, or question.
SG Carruthers (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: